Onco-neural antibodies and tumour type determine survival and neurological symptoms in paraneoplastic neurological syndromes with Hu or CV2/CRMP5 antibodies

✍ Scribed by Honnorat, J. (author);Cartalat-Carel, S. (author);Ricard, D. (author);Camdessanche, J. Ph (author);Carpentier, A. F. (author);Rogemond, V. (author);Chapuis, F. (author);Aguera, M. (author);Decullier, E. (author);Duchemin, A. M. (author);Graus, F. (author);Antoine, J. C. (author)

• Book ID: 115505246
• Publisher: BMJ Publishing Group
• Year: 2008
• Tongue: English
• Weight: 196 KB
• Volume: 80
• Category: Article
• ISSN: 0022-3050
• DOI: 10.1136/jnnp.2007.138016